Batch Release Testing and QP Certification: The Backbone of Pharmaceutical Quality Assurance
Are strict pharmaceutical regulations slowing your EU market entry? You're not alone. Navigating the complex landscape of batch release testing can be challenging, particularly for pharmaceutical manufacturers outside the EU.
Conscio Group at CPHI 2025 in Frankfurt – Meet Us in Hall 5.1, Stand F1
This October, the global pharmaceutical community will gather in Frankfurt for CPHI 2025. Conscio Group will be there too –
From Analytical Similarity to Clinical Data: Tailoring Evidence for Biosimilar Approval
Registration is now open for our free expert-led webinar on the evolving evidence requirements for biosimilar approval.
The Benefits of FTE Contracts for Pharmaceutical Companies
How can an FTE-based partnership with a CRO transform your pharmaceutical development?
Conscio Group Appoints Gary Chambers as Executive Vice President of Strategy and Marketing
April 3, 2025 – Conscio Group, a leading scientific service provider for the pharmaceutical industry, announces the appointment of Gary
Expediting Biosimilar development: Streamlining the path from research to market
A free webinar on the future of biosimilar pathway to approval is now available for registration
Conscio Group and Kiel Labs Announce Strategic Partnership
Conscio Group, a European network of GMP/GLP/GCP/IEC-certified contract R&D service providers, and Kiel Laboratories, Inc., a leading U.S. pharmaceutical research
